What must a med spa in Florida report to the board?
Facility · part of The Practice Perimeter
Short answer
Yes — for office surgery, the surgeon must report any adverse incident to the Department of Health within 15 days and run a risk-management program analyzing incidents, reviewed at least quarterly. Board filings cover APRN protocols and offsite addresses.
⚠️ Florida’s office-surgery rule carries the adverse-incident report, and the clock is 15 DAYS. “The surgeon shall report to the Department of Health any adverse incidents that occur within the office surgical setting. This report shall be made within 15 days after the occurrence of an incident” as required by Section 458.351, F.S. The same rule requires the surgeon to run a risk-management program identifying, investigating and analyzing the frequency and causes of adverse incidents, with documentation reviewed no less than quarterly.
Fla. Admin. Code r. 64B8-9.009(2)(l)-(m) (adverse incident reporting and risk management) · verified Sep 8, 2026 · regulatory monitoring, not legal advice
Related Florida rules
⚠️ the supplier of a compounded injectable needs a Florida permit, and this is checkable. “in order to ship, mail, deliver, or dispense, in any manner, a compounded sterile product into this state, a nonresident pharmacy registered under s. 465.0156, or an outsourcing facility, must hold a nonresident sterile compounding permit.” Compounded semaglutide is a sterile product; a Florida practice buying it from out of state should ask to see this permit before the first delivery.
Fla. Stat. § 465.0158(1) · verified Sep 2, 2026
What the permit requires is a paper trail and a signed promise. The applicant must give the board proof of registration as an outsourcing facility with the federal Department of Health and Human Services where eligible under the Drug Quality and Security Act, proof of nonresident pharmacy registration or an active unencumbered home-state license permitting it to compound and ship into Florida, and “written attestation by an owner or officer of the applicant, and by the applicant’s prescription department manager or pharmacist in charge” that they have read the state’s sterile compounding rules and that product shipped in “meets or exceeds this state’s standards for sterile compounding”.
Fla. Stat. § 465.0158(3) · verified Sep 2, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- Delaware
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- New Jersey
- New Mexico
- Ohio
- Pennsylvania
- Texas
- West Virginia
Related Florida questions
- Does a med spa have to register or hold a license in Florida?
- What are the license fees to open a med spa in Florida?
Get Florida changes as they publish
We scan the Florida legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Florida rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).